Measurement of antiphospholipid antibody by ELISA using purified β2-glycoprotein I in preeclampsia

Publisher Website
Google Scholar
Abstract
SUMMARY: It has been reported that the binding of some antiphospholipid antibodies (APA) to phospholipids requires the presence of β2-glycoprotein 1 (β2-GPI). Using a new ELISA, in which well coated phospholipids were treated with a constant amount of purified β2-GPI. we tried to detect the presence of APA which binds to phospholipid/β2-GPI complex or to phospholipids such as cardiolipin (CA) and phosphatidylserine (PS) in preeclampsia. and to check for clinical abnormalities in antibodypositive cases. Serum samples were taken from 43 cases of preeclampsia. including 26 cases of the severe type, and 47 normal pregnant women. Positive rates of anticardiolipin antibody (ACA) by ELISA using CA/β2-GPI complex in mild, severe and total preeclampsia were 20·0%, 17·4% and 18·4% respectively. No antibody-positive cases were found in normal pregnancies. ACA was detected much more frequently when cardiolipin/β2-GPI complex was used in ELISA compared with ELISA without β2-GPI. Positive rales of antiphosphatidylserine antibody (APSA) in mild, severe and total preeclampsia were 5·9%, 11·5% and 9·3% respectively. APSA was also detected much more frequently when the phosphatidylserine/β2-GPI complex was used in ELISA. The frequency of intraulerine growth retardation (IUGR) in the ACA-positive subjects was higher than that of ACA negatives. We suggest that the ACA and APSA which bind to phospholipid/β2-GPI complex are detectable in preeclampsia, and that these antiphospholipid antibodies are related to fetal growth.